Veracyte | VCYT - Trade Creditors

Stock Price
41.71
Daily Change
0.21 0.51%
Monthly
24.69%
Yearly
44.78%
Q2 Forecast
37.71

Veracyte reported $6.91M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Agenus USD 71.08M 11.9M Mar/2026
Agilent USD 602M 32M Dec/2025
Anika Therapeutics USD 6.34M 298K Mar/2026
Arrowhead Research USD 30.75M 2.19M Mar/2026
Bruker USD 269.1M 53.2M Mar/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Illumina USD 218M 22M Mar/2026
Intrexon USD 4.85M 3.12M Jun/2024
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Laboratory Of America USD 695.7M 145.1M Mar/2026
Ligand Pharmaceuticals USD 37.11M 33.87M Mar/2026
Myriad Genetics USD 32.6M 2.6M Mar/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Siemens EUR 8.95B 378M Mar/2026
Sonic Healthcare AUD 313.54M 543.93M Jun/2024
Thermo Fisher Scientific USD 3.34B 278M Mar/2026
Veracyte USD 6.91M 2.32M Mar/2026
Waters USD 103.78M 11.95M Dec/2025